Biobanking involves the collection, processing, storage and distribution of biospecimens and data, and, in recent years, it has rapidly evolved to become an integral component in biomedical research.1 Biobanks may range in complexity from a single researcher storing their own material to large stores of material used by multiple researchers. This diversity has complicated the standardisation of biobanking practices,2,3 sometimes compromising biospecimen quality and storage capacity4 and the security of funding. In turn, irreproducible research results, poor biospecimen access and decreased public confidence may ensue.4
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Gedye C, Fleming J. Forsaking cures for cancer: why are we discarding the tumour biospecimens of most patients? Med J Aust 2016; 204: 297-298. <MJA full text>
- 2. Rush A, Byrne JA. Quality and reporting practices in an Australian cancer biobank cohort. Clin Biochem 2016; 49: 492-497.
- 3. Moore HM. Moving toward biospecimen harmonization with evidence-based practices. Biopreserv Biobank 2014; 12: 79-80.
- 4. Simeon-Dubach D, Watson P. Biobanking 3.0: evidence based and customer focused biobanking. Clin Biochem 2014; 47: 300-308.
- 5. Barnes RO, Shea KE, Watson PH. The Canadian Tissue Repository Network Biobank Certification and the College of American Pathologists Biorepository Accreditation programs: two strategies for knowledge dissemination in biobanking. Biopreserv Biobank 2016; 15: 9-16.
No relevant disclosures.